SUSHMA SHIVASWAMY - 10 Feb 2023 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Chief Scientific Officer
Signature: /s/ Angela Hu under Power of Attorney for Sushma Shivaswamy
Issuer symbol: XBIT
Transactions as of: 10 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2023, 19:00:49 UTC
Previous filing: 23 Nov 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XBIT	Employee Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	10 Feb 2023	Common Stock	100,000	$3.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 10, 2023 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in two years commencing as of August 10, 2023, with an expiry of ten years from the Grant Date.

Content

On February 10, 2023 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in two years commencing as of August 10, 2023, with an expiry of ten years from the Grant Date.